Lansforsakringar Fondforvaltning’s Bristol-Myers Squibb BMY Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40M	Sell	659,076 -104,772	-14%	-$6.11M	0.21%	90
2025 Q4	$41.2M	Buy	763,848 +6,611	+0.9%	+$318K	0.2%	97
2025 Q3	$34.2M	Buy	757,237 +16,240	+2%	+$758K	0.18%	104
2025 Q2	$34.3M	Sell	740,997 -28,407	-4%	-$1.39M	0.2%	92
2025 Q1	$46.9M	Sell	769,404 -888	-0.1%	-$51.8K	0.29%	72
2024 Q4	$43.6M	Buy	+770,292	New	+$43M	0.24%	81

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lansforsakringar Fondforvaltning's BMY Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $6.11M and leaving 659,076 shares worth $40M. The position accounts for 0.21% of the portfolio, ranked #90.

Lansforsakringar Fondforvaltning first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $46.9M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Lansforsakringar Fondforvaltning held 659,076 shares of Bristol-Myers Squibb worth $40M as of Q1 2026.
Lansforsakringar Fondforvaltning sold 104,772 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.11M.
Bristol-Myers Squibb made up 0.21% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #90 holding.
Lansforsakringar Fondforvaltning first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
Lansforsakringar Fondforvaltning's Bristol-Myers Squibb position peaked at $46.9M in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.